Now in its 29th year, Young & Partners has been a focused chemical and life science industry investment bank serving the strategy consulting, M&A, financing and financial advisory needs of clients in North America, Europe, Asia and South America. Our senior members have extensive senior level investment banking, corporate strategy and operating/regulatory experience.
Our focus is on providing excellent management of all transactions by senior investment bankers, exceptional technical investment banking expertise, proprietary and in-depth industry knowledge, a pristine reputation, and the absence of any conflicts of interest. We are unique in that we are able to integrate first rate corporate and financial strategy expertise in a way other firms cannot.
The Firm is a licensed broker-dealer and a member of the FINRA and SIPC.
Young & Partners provides extensive services to clients of all sized in the areas of:
- Corporate Business and Financial Strategy Consulting
- Mergers & Acquisitions
- Divestitures
- Financial restructuring and bankruptcy advisory services
- Capital raising through private placements
- General financial advisory services
The Firm’s activities and projects are frequently international and cross border in nature.
The senior members of the Firm have completed a large number of transactions and financings for companies on a global basis over many years.
We have an extensive internal R&D capacity that results in proprietary analyses of industry strategic, M&A, financing, stock market and valuation drivers and trends that are our tools to give powerful and differentiated advice and project execution.
For many years, the Firm has sponsored the leading Senior Chemical Executive Conference every fall on “Strategic, Financial and Shareholder Issues for Chemical Executives”.
The Firm has also hosted an annual “Pharmaceutical Executive Summit” for 16 years that connects senior industry executives and features speakers on important biotech and pharma topics.